top of page

Trends in Incident Prescriptions for Behavioral Health Medications in the US, 2018-2022

  • Jan 19, 2024
  • 1 min read

Trends in Incident Prescriptions for Behavioral Health Medications in the US, 2018-2022, in JAMA Psychiatry


key takeaway: "Trends in the number of incident prescriptions dispensed nationally for Schedule II (C-II) stimulant and nonstimulant medications for attention-deficit/hyperactivity disorder (ADHD) significantly increased during the COVID-19 pandemic, exceeding prepandemic rates, notably in young adults and women. Incident prescription trends for antidepressants, benzodiazepines, and buprenorphine for opioid use disorder did not significantly change."

Recent Posts

See All
Cannabis and Mental Health: A Review

Cannabis and Mental Health: A Review , in JAMA Internal Medicine key takeaway: "The current evidence base is not sufficient to support the use of cannabis for the treatment of mental health conditions

 
 
 

Comments

bottom of page